bioAffinity Technologies BIAF Cash Flow Statement (2021-2026)

NASDAQ BIAF
$3.66 +0.15 (+4.27%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

bioAffinity Technologies Quarterly Cash Flow Statement

Periods 20 quarters
Latest Jun 2026

bioAffinity Technologies reported cash from operations of -$3.20M and free cash flow of -$3.29M for the quarter ended Jun 2026, down 20.9% year over year. This cash flow statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M-3.37M
Depreciation and DepletionDep. & Depletion 0.00M0.00M800.000.01M0.02M0.02M0.05M0.17M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.02M0.02M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 794.000.00M0.00M773.000.01M0.02M0.02M0.06M0.15M0.15M0.15M0.15M0.15M0.15M0.11M0.11M0.12M0.11M0.06M
Share-based CompensationStock Comp. -89.52M0.11M0.03M0.08M0.04M0.16M0.17M0.09M0.23M0.28M0.29M0.19M0.23M0.33M0.22M0.07M0.07M0.01M0.78M
Other non-cash itemsOther Non-Cash 4.56M0.98M-0.21M0.77M0.08M2.75M
Change in Working Capital
Change in ReceivablesChange Receivables 0.01M956.000.00M559.00538.000.08M-0.15M-0.24M0.31M0.47M-0.27M-0.19M-0.18M-0.54M0.03M0.09M0.14M0.21M
Change in InventoryChange Inventory 0.01M-146.0058.00-175.000.01M0.00M-193.000.01M-0.01M0.02M0.00M0.00M0.01M0.01M-0.01M0.02M0.02M0.00M
Change in Account PayablesChange Payables -0.03M0.02M0.34M-0.44M0.20M-0.20M0.03M0.58M-0.42M-0.22M0.46M-0.07M0.20M0.39M-0.21M-0.23M-0.18M0.07M0.13M
Change in Accured ExpensesChange Accured Exp. 0.16M0.17M0.17M0.13M-0.03M-0.06M0.03M-0.12M0.51M-0.27M0.09M-0.06M0.49M-0.03M-0.32M-0.06M0.73M0.31M-0.61M
Change in Other Operating AssetsOther Assets Change -0.02M-0.01M-0.02M0.53M-0.01M-0.09M-0.16M0.09M-0.06M0.02M-0.09M0.19M-0.02M-0.01M-0.02M0.06M0.06M-0.07M-0.01M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M-0.01M0.00M0.00M0.00M0.00M-0.01M
Other Working Capital ChangesOther WC Changes 0.02M0.01M0.02M-0.53M0.01M0.09M0.16M-0.10M0.06M-0.03M0.08M-0.19M0.02M0.01M0.02M-0.06M-0.06M0.06M0.01M
Cash from OperationsCash from Ops. -0.65M-0.63M-0.38M-1.76M-1.30M-1.53M-1.36M-1.53M-1.62M-2.35M-1.53M-1.71M-1.68M-1.64M-2.65M-2.48M-2.56M-3.23M-3.20M
Investing Activities
Capital ExpendituresCapex 0.03M0.00M169.00-0.01M0.04M0.03M0.01M1.000.05M0.01M0.00M1.000.01M0.09M
Change in Property, Plant and EquipmentChange in PP&E -0.03M0.00M-169.000.01M-0.04M-0.03M-0.01M-1.00-0.05M-0.01M0.00M-1.00-0.01M-0.09M
Cash from Investing ActivitiesCash from Investing -0.03M0.00M-2.19M0.01M-0.04M-0.03M-0.01M-1.00-0.05M-0.01M0.00M-1.00-0.01M-0.09M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 1.95M0.48M0.80M-0.56M
Long-Term Debt RepaymentsLT Debt Repayment 0.03M0.02M0.08M0.13M-0.20M0.08M0.09M0.09M0.09M0.09M0.10M0.09M0.06M0.07M0.08M0.02M
Non-Current Debt 1.95M0.48M0.77M-0.58M-0.08M-0.13M0.20M-0.08M-0.09M-0.09M-0.09M-0.09M-0.10M-0.09M-0.06M-0.07M-0.08M-0.02M
Short-Term Debt issuancesST Debt Issuance 0.03M-851.000.26M-0.10M
Short-Term Debt repaymentsST Debt Repayment 0.08M0.13M0.04M0.04M0.07M-0.10M0.04M0.05M
Current Debt -0.08M-0.13M-0.04M0.03M-851.000.26M-0.10M-0.04M-0.07M0.10M-0.04M-0.05M
Net Debt Issuances and RepaymentsNet Debt Issuance 1.95M0.48M0.77M-0.58M-0.17M-0.25M0.16M-0.08M-0.06M-0.09M0.17M-0.19M-0.14M-0.17M0.04M-0.07M-0.12M-0.07M
Change in Capital Stock
Common Stock IssuedStock Issued 2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M
Net Shares Issued and RepurchasedNet Shares Issued 2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M
Net Equity Issued and RepurchasedNet Equity Issued 2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M
Other financing activitiesOther financing -0.17M-0.40M0.52M-0.48M1.07M
Cash from Financing ActivitiesCash from Financing 1.77M0.30M-0.44M15.04M-0.56M-0.08M-0.13M-0.05M-0.08M2.02M-0.09M1.67M2.03M1.03M3.02M9.34M1.34M-0.12M2.62M
Additional items
Change in Cash 1.12M-0.33M-0.81M13.28M-2.08M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M
Ending Cash Balance 0.24M1.36M1.03M0.21M13.50M11.41M9.77M8.28M4.51M2.82M2.45M0.80M0.76M1.11M0.44M0.80M7.67M6.45M3.10M2.43M
Free Cash FlowFCF -0.65M-0.63M-0.38M-1.76M-1.30M-1.56M-1.36M-1.53M-1.60M-2.39M-1.56M-1.72M-1.68M-1.69M-2.66M-2.48M-2.56M-3.23M-3.29M
Net Cash FlowNCF 1.12M-0.33M-0.81M13.28M-1.86M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M
Interest Paid 0.01M-0.01M0.01M0.03M0.02M0.02M-0.03M0.00M542.000.00M0.00M0.04M0.01M0.00M
Income Taxes PaidTaxes Paid 0.00M0.00M0.03M0.00M0.01M0.00M0.00M0.00M0.01M0.00M0.01M0.01M0.03M0.00M-0.02M

bioAffinity Technologies Cash Flow Statement API

Pull bioAffinity Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIAF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY